Callan Family Office’s Nasdaq NDAQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$821K Sell
10,417
-317
-3% -$27.8K 0.02% 659
2026
Q1
$911K Sell
10,734
-1,742
-14% -$156K 0.02% 590
2025
Q4
$1.21M Buy
12,476
+3,943
+46% +$355K 0.03% 498
2025
Q3
$755K Sell
8,533
-916
-10% -$84.8K 0.02% 429
2025
Q2
$845K Buy
9,449
+3,096
+49% +$247K 0.03% 440
2025
Q1
$482K Buy
6,353
+1,101
+21% +$86.6K 0.04% 331
2024
Q4
$406K Buy
+5,252
New +$406K 0.03% 415

Other funds holding NDAQ

Callan Family Office's NDAQ Position: Q2 2026 in Review

Callan Family Office reduced its Nasdaq (NDAQ) stake by 3% in Q2 2026, selling an estimated $27.8K and leaving 10,417 shares worth $821K. The position accounts for 0.02% of the portfolio, ranked #659.

Callan Family Office first reported a position in NDAQ in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.21M in Q4 2025. 1,089 funds tracked by Wall St. Rank hold NDAQ as of Q2 2026.

  • Callan Family Office held 10,417 shares of Nasdaq worth $821K as of Q2 2026.
  • Callan Family Office sold 317 Nasdaq shares in Q2 2026, an estimated $27.8K.
  • Nasdaq made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #659 holding.
  • Callan Family Office first reported a position in Nasdaq in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Nasdaq position peaked at $1.21M in Q4 2025.
  • 1,089 funds tracked by Wall St. Rank held Nasdaq as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.